Nicotine - Older Adults (50+): Difference between revisions

Line 60: Line 60:
**Citation: Le Grande M, Borland R, Yong HH, McNeill A, Fong G, Cummings KM. Age-Related Interactions on Key Theoretical Determinants of Smoking Cessation: Findings from the ITC Four Country Smoking and Vaping Surveys (2016-2020). Nicotine Tob Res. 2022 Mar 26;24(5):679-689. doi: 10.1093/ntr/ntab230. PMID: 34755869; PMCID: PMC9122748.
**Citation: Le Grande M, Borland R, Yong HH, McNeill A, Fong G, Cummings KM. Age-Related Interactions on Key Theoretical Determinants of Smoking Cessation: Findings from the ITC Four Country Smoking and Vaping Surveys (2016-2020). Nicotine Tob Res. 2022 Mar 26;24(5):679-689. doi: 10.1093/ntr/ntab230. PMID: 34755869; PMCID: PMC9122748.
***Acknowledgement: The ITC Four Country Smoking and Vaping Project in Australia, Canada, US, and England was supported by the National Health and Medical Research Council of Australia (APP1106451), US National Cancer Institute (P01CA200512), and Canadian Institutes of Health Research (FDN-148477). GTF was supported by a Senior Investigator Grant from the Ontario Institute for Cancer Research. GTF has served as an expert witness on behalf of governments in litigation involving the tobacco industry. KMC has been a consultant and received grant funding from the Pfizer Inc. in the past 5 years. K.M.C has also been a paid expert witness in litigation against the tobacco industry. All other authors have no conflicts of interest to declare.
***Acknowledgement: The ITC Four Country Smoking and Vaping Project in Australia, Canada, US, and England was supported by the National Health and Medical Research Council of Australia (APP1106451), US National Cancer Institute (P01CA200512), and Canadian Institutes of Health Research (FDN-148477). GTF was supported by a Senior Investigator Grant from the Ontario Institute for Cancer Research. GTF has served as an expert witness on behalf of governments in litigation involving the tobacco industry. KMC has been a consultant and received grant funding from the Pfizer Inc. in the past 5 years. K.M.C has also been a paid expert witness in litigation against the tobacco industry. All other authors have no conflicts of interest to declare.
===2021: [https://pmc.ncbi.nlm.nih.gov/articles/PMC7885790/ Intensive Longitudinal Study of the Relationship Between Cigalike E-cigarette Use and Cigarette Smoking Among Adult Cigarette Smokers Without Immediate Plans to Quit Smoking]===
*Smokers older than 45 and those who started smoking at a younger age rated e-cigarettes as less satisfying (ps < .05). Participants with greater than the median reported satisfaction were 6.5 times more likely to use an e-cigarette at follow-up.
**Citation: Pearson JL, Zhou Y, Smiley SL, Rubin LF, Harvey E, Koch B, Niaura R, Abrams DB. Intensive Longitudinal Study of the Relationship Between Cigalike E-cigarette Use and Cigarette Smoking Among Adult Cigarette Smokers Without Immediate Plans to Quit Smoking. Nicotine Tob Res. 2021 Feb 16;23(3):527-534. doi: 10.1093/ntr/ntaa086. Erratum in: Nicotine Tob Res. 2024 Dec 23;27(1):163. doi: 10.1093/ntr/ntae234. PMID: 32421191; PMCID: PMC7885790.
***Acknowledgement: The research reported in this publication was supported by the National Institute on Drug Abuse (grant number 1R21DA036472) of the National Institutes of Health under grant number 5R21DA036472. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. [https://pmc.ncbi.nlm.nih.gov/articles/PMC7885790/#s0106 Disclosures]


===2020: [https://www.sciencedirect.com/science/article/pii/S0085253815469595 Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population]===
===2020: [https://www.sciencedirect.com/science/article/pii/S0085253815469595 Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population]===